Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

TA Associates makes $2.8 billion takeover approach for Smiths Group unit - Mail on Sunday

Published 12/07/2021, 01:42
Updated 12/07/2021, 01:45
© Reuters.

(Reuters) - U.S. private equity firm TA Associates has made a 2 billion pounds ($2.78 billion) takeover approach for the medical division of Smiths Group (LON:SMIN) Plc, which makes ventilators for hospitals, the Mail on Sunday reported https://

A successful sale would see Smiths Group, which is valued at 6.5 billion pounds and has 23,100 staff, effectively broken up, the report added, citing sources.

Smiths Group has been holding talks with Boston-based TA Associates and bankers from Goldman Sachs (NYSE:GS) are said to be working on the deal, according to the report, which said talks were at an advanced stage.

TA Associates and Smiths Group were not immediately available for comment.

($1 = 0.7194 pounds)

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.